AD-4833

· Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-4833, covering 2023-08-31 to 2023-08-31. Get the full timeline:

Most recent: Clinical Trial Update: A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322 [Phase 4]